A carregar...
Research Progress on Resistance Mechanisms of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Non-small Cell Lung Cancer
With a greater understanding of tumor biology, novel molecular-targeted strategies that block cancer progression pathways have been evaluated as a new therapeutic approach for treating non-small cell lung cancer (NSCLC). Epidermal growth factor receptor-tyrosine kinase inhibitors (EGFR-TKIs), such a...
Na minha lista:
| Main Authors: | , |
|---|---|
| Formato: | Artigo |
| Idioma: | Chinês |
| Publicado em: |
Chinese Anti-Cancer Association; Chinese Antituberculosis Association
2012-02-01
|
| Colecção: | Chinese Journal of Lung Cancer |
| Assuntos: | |
| Acesso em linha: | http://dx.doi.org/10.3779/j.issn.1009-3419.2012.02.08 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|